|
⚲
|
| Keyboard |
| Lazarus Alon
✚
|
|
|---|---|
| CIK # | 0001808244 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001808244] | |
| 4 | [0001808244] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Lazarus Alon | |
| Werewolf Therapeutics Inc | |
| Keros Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Werewolf Therapeutics Inc HOWL
Stock Option (right to buy) · derivative
|
2025-06-12 | Grant | 27,000 | $0.00 | |
|
Werewolf Therapeutics Inc HOWL
Stock Option (right to buy) · derivative
|
2024-05-24 | Grant | 17,500 | $0.00 | |
|
Werewolf Therapeutics Inc HOWL
Stock Option (right to buy) · derivative
|
2023-06-21 | Grant | 13,200 | $0.00 | |
|
Werewolf Therapeutics Inc HOWL
Stock Option (right to buy) · derivative
|
2022-06-01 | Grant | 11,600 | $0.00 | |
|
Werewolf Therapeutics Inc HOWL
Series B Preferred Stock · derivative
|
2021-05-04 | Conversion | 3,560,551 | $0.00 | |
|
Werewolf Therapeutics Inc HOWL
Common Stock
|
2021-05-04 | Buy | 400,000 | $16.00 | 6,400,000 |
|
Werewolf Therapeutics Inc HOWL
Common Stock
|
2021-05-04 | Conversion | 410,717 | ||
|
Werewolf Therapeutics Inc HOWL
Common Stock
|
2021-05-04 | Conversion | 1,235,917 | ||
|
Werewolf Therapeutics Inc HOWL
Series A Preferred Stock · derivative
|
2021-05-04 | Conversion | 10,714,284 | $0.00 | |
|
Werewolf Therapeutics Inc HOWL
Stock Option (right to buy) · derivative
|
2021-04-30 | Grant | 23,200 | $0.00 | |
|
Werewolf Therapeutics Inc HOWL
Series B Preferred Stock · derivative
|
2020-12-23 | Buy | 3,560,551 | $0.92 | 3,275,707 |
|
Keros Therapeutics Inc KROS
Common Stock
|
2020-04-13 | Conversion | 343,270 | ||
|
Keros Therapeutics Inc KROS
Common Stock
|
2020-04-13 | Conversion | 167,537 | ||
|
Keros Therapeutics Inc KROS
Common Stock
|
2020-04-13 | Buy | 120,000 | $16.00 | 1,920,000 |
|
Keros Therapeutics Inc KROS
Series A Preferred Stock · derivative
|
2020-04-13 | Conversion | 1,382,295 | $0.00 | |
|
Keros Therapeutics Inc KROS
Series C Preferred Stock · derivative
|
2020-04-13 | Conversion | 167,537 | $0.00 | |
|
Keros Therapeutics Inc KROS
Series B-1 Preferred Stock · derivative
|
2020-04-13 | Conversion | 343,270 | $0.00 | |
|
Keros Therapeutics Inc KROS
Common Stock
|
2020-04-13 | Conversion | 1,382,295 |